Prosecution Insights
Last updated: October 04, 2026

Ipsilon Usa - Nlo

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

152 pending office actions • 76 clients • 136 examiners • 76 art units • 0 of 152 (0%) have an AI response strategy ready • 137 patents granted in the last 365 days

Analysis

Ipsilon USA - NLO has managed 2645 career applications in the Biotechnology & Pharmaceuticals technology area. The firm currently has 123 pending office actions and a resolved allowance rate pct of 81.43.

Prosecution at the firm involves an avg office actions per allowance of 3.37. This 3.37 figure provides a basis for practitioners to anticipate the number of examiner interactions required in the Biotechnology & Pharmaceuticals sector. The 81.43 resolved allowance rate pct reflects the proportion of cases that reached allowance relative to the 2645 career applications. The 123 pending office actions represent the current cases awaiting a USPTO response.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=2645 apps, methodology: how we score firms)

81.4%
Allowance Rate
n=2645
+0.53σ
Allowance Rate (norm)
n=2645
3.4
OAs to Allowance
n=1399
-0.17σ
OAs to Allow (norm)
n=1399
1065 days
Time to Allowance
n=1399
+14.2pp
Interview Lift
n=2645
33.2%
RCE Rate
n=2645
2.3%
Appeal Rate
n=2645

Rejection Performance (% of received rejections ultimately overcome)

64.9%
§101 Overcome
n=148
68.8%
§102 Overcome
n=664
62.8%
§103 Overcome
n=1345
65.1%
§112 Overcome
n=1302

Specialization & Scale

A61K, A23L, A61P
Top CPC Subclasses
15%
Top-3 CPC Share
n=2645
0
Practitioners
n=2645
—
Apps / Practitioner
n=2645 (min 20)

Portfolio Summary

152
Total Pending OAs
87
Non-Final OAs
59
Final Rejections
6
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 68 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

37
Overdue
1
Due this week
18
Due this month
7
Due in next 60 days
5
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 68 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (37)Due ≤ 7 days (1)Due ≤ 30 days (18)Due ≤ 60 days (7)Due later (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

79
Hard (52%)
63
Medium (41%)
8
Easy (5%)
2
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only2 (1%)
§101 + other6 (4%)
§103 only43 (28%)
§102 only3 (2%)
§112 only6 (4%)
Double-patenting only2 (1%)
Double-patenting + other17 (11%)
Multi-statute (no §101)71 (47%)
No statute on record2 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

99
Life Sciences
65% of docket
2
Information Tech
1% of docket
1
Communications
1% of docket
1
Semiconductors
1% of docket
23
Mechanical / Eng
15% of docket
26
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,520 h
Manual time on pending OAs
304 h
Time saved (low, 20%)
532 h
Time saved (mid, 35%)
13.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LANGEL, WAYNE A 3 78.4% +23.2%
HUYNH, PHUONG N 3 65.7% +53.6%
BOECKELMAN, JACOB A 2 35.2% +45.6%
YOO, HONG THI 2 45.8% +26.0%
HIBSHMAN, SARAH GRACE 2 38.9% +40.0%
LIU, DEBORAH YANG-HAO 2 8.9% +12.3%
GWARTNEY, ELIZABETH A 2 36.0% +34.8%
LIPPOLIS, ALEXANDRA ROSE 2 46.9% +59.0%
SKOKO III, JOHN JOSEPH 2 53.1% +58.2%
SHELLHAMMER, JAMES PAUL 2 10.0% +18.8%

Hard Cases (81)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17797450 THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA PEEBLES, KATHERINE 189d overdue
17760508 Method for the conversion of insects into nutrient streams and products resulting therefrom LACHICA, ERICSON M 60d overdue
18043595 OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS OGUNBIYI, OLUWATOSIN A 53d overdue
18042779 OPHTHALMIC DYE VU, JAKE MINH 53d overdue
18311910 Method for providing dynamically customized messages in a healthcare facility BALAJ, ANTHONY MICHAEL 49d overdue
18001290 METHOD FOR SEPARATION OF POTATO PROTEINS AND INSOLUBLE FIBERS FROM PHENOLIC AND/OR GLYCOALKALOID COMPOUNDS SHELLHAMMER, JAMES PAUL 44d overdue
17917265 REMOVING WATER-SOLUBLE HEAVY METAL-SULFUR COMPLEX FROM PROCESS SOLUTION KEYWORTH, PETER 43d overdue
18563934 HYDROTHERMAL TREATMENT OF BIOMASS HINES, LATOSHA D 36d overdue

Interview Candidates (22)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18001290 METHOD FOR SEPARATION OF POTATO PROTEINS AND INSOLUBLE FIBERS FROM PHENOLIC AND/OR GLYCOALKALOID COMPOUNDS SHELLHAMMER, JAMES PAUL 44d overdue
17797986 COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES LIPPOLIS, ALEXANDRA ROSE 5d overdue
17312193 SAPONIN CONJUGATED TO EPITOPE-BINDING PROTEINS HUYNH, PHUONG N 22d
18012741 COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE SKOKO III, JOHN JOSEPH 26d
18264085 TWO-STAGE COOLING PROCESS FOR LARVAE PUREE LIU, DEBORAH YANG-HAO 56d
17508481 USE OF VANADIUM COMPOUNDS FOR MAINTAINING NORMAGLYCEMIA IN A MAMMAL BOECKELMAN, JACOB A 70d
18882804 Nutritional composition for cancer BOECKELMAN, JACOB A —
18741853 Mix of specific Bifidobacterium species and specific non-digestible oligosaccharides YOO, HONG THI —

Client Portfolio (76 clients)

Client (Assignee)Pending OAs
Danone 19
Unilever 13
SAPREME TECHNOLOGIES B.V. 10
KEYGENE N.V. 4
Crea IP 4
UNIVERSITEIT GENT 4
Radboud University 4
uniQure 4
Protix B.V. 4
VMI HOLLAND B.V. 3
Tessenderlo Group NV 3
UMC UTRECHT HOLDING B.V. 3
Barlaa B.V. 2
Micreos 2
Vitreq B.V. 2
Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis 2
Cobra Beheer B.V. 2
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN 2
INTRAVACC B.V. 2
The Protein Brewery B.V. 2
Duynie Holding 2
Tessenderlo Kerley, Inc. 2
Danmarks Tekniske Universitet 2
ACADEMISCH ZIEKENHUIS MAASTRICHT 2
Cosun 2
Mpac Langen B.V. 1
Roederer Management B.V. 1
Ultimaker B.V. 1
Maridea B.V. 1
Volvo Group 1
Haskoningdhv Nederland B.V. 1
Three Peaks Medical Pty Ltd. 1
Nulife B.V. 1
Celyntra Therapeutics SA 1
FAM 1
Novumgen Limited 1
UNIVERSITEIT UTRECHT HOLDING B.V. 1
Novelyeast BV 1
IHC Holland IE B.V. 1
WAGENINGEN UNIVERSITEIT 1
Carbonx Ip 10 B.V. 1
Campagnolo 1
Mireca Medicines GmbH 1
INDIAN INSTITUTE OF SCIENCE 1
Thermosome GmbH 1
Dripel B.V. 1
Arteco NV 1
Nederlandse Organisatie Voor Toegepast-natuurwetenschappelijk Onderzoek Tno 1
NapiFeryn BioTech sp. z o.o 1
TEN CATE THIOLON B.V. 1
Sentea NV 1
E-Magy B.V. 1
Xero Pharmaceuticals 1
Nextkidney Sg Pte. Ltd. 1
INSTRUCTURE LABS B.V. 1
Carbonx B.V. 1
TOOLS4PATIENT 1
Linxis B.V. 1
CFM Pharma Holding B.V. 1
ULB 1
Tchüpp GmbH 1
Pharming Intellectual Property B.V. 1
Perfetti Van Melle Benelux B.V. 1
UNIVERSITEIT TWENTE 1
Immunological and Medicinal Products, SL 1
Nutraceutical Wellness Inc. 1
ALEGRE USA LLC 1
Arteco 1
Cfm Pharma Holding BV 1
Synvolux IP B.V. 1
Chrono Eyewear B.V. 1
NO-ceuticals B.V. 1
Amphera B.V. 1
Stichting Katholieke Universiteit 1
Enzyre B.V. 1
ENERGY SOLUTIONS (US) LLC 1

Top Art Units

Art UnitApps
17918
17926
16376
16935
16414
17593
16513
17313
17773
16632

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19480379 A SYSTEM AND METHOD FOR SEPARATING A STACK OF CARTON PAPERS Mpac Langen B.V. SEVERSON, JEREMY R 1759 §112 Non-Final OA — Pending Oct 31, 2025
19135838 REGENERATION BY PROTOPLAST CALLUS GRAFTING Keygene N.V. SHEN, YANXIN NMN 1663 §112 Non-Final OA — Pending Jun 05, 2025
19226320 PROCESSING AND DISTRIBUTING A DISTRIBUTION SCHEME Roederer Management B.V. GUNDRY, STEPHEN T 2431 §101§103§112 Non-Final OA — Pending Jun 03, 2025
19209115 METHOD FOR TARGETED ALTERATION OF DUPLEX DNA Keygene N.V. ZHENG, LI 1662 §103 Non-Final OA — Pending May 15, 2025
19171508 Card Based Lid with Scoop Holder and Scoop N.V. Nutricia ORTIZ, RAFAEL ALFREDO 3736 §103§112 Non-Final OA — Pending Apr 07, 2025
19107064 SILICIC ACID FOR IMPROVING MILK PRODUCTION IN DAIRY LIVESTOCK Barlaa B.V. LI, WENHAN 1616 §103§112Other Non-Final OA — Pending Feb 27, 2025
19106659 HYDROGEL-CARRIERS FOR INDUCTION OF PLANT MORPHOGENESIS Keygene N.V. WILLIAMS, KEITH RICHARD §103§112 Non-Final OA — Pending Feb 26, 2025
19038723 SYNERGISTIC COMPOSITIONS FOR IMPROVING MINERAL BIOACCESSIBILITY Nutricia Early Life Nutrition (Shanghai) Co., Ltd. PACKARD, BENJAMIN J §103§112DP Non-Final OA — Pending Jan 28, 2025
18985099 FFF PRINTING SYSTEM WITH A FILAMENT PATH LENGTH MEASURING DEVICE FOR ALIGNMENT OF FEEDER AND PREFEEDER Ultimaker B.V. CHIDIAC, NICHOLAS J 1744 §103DP Non-Final OA — Pending Dec 18, 2024
18874590 Injector device Crea Ip B.V. ZIMBOUSKI, ARIANA §102§103§112DP Non-Final OA — Pending Dec 13, 2024
18874123 FLOATING FOUNDATION FOR AN OFFSHORE WIND TURBINE AND METHOD OF CONSTRUCTION Maridea B.V. HAYES, JOVON E §102§103§112 Non-Final OA — Pending Dec 12, 2024
18961534 Lidar based Road Condition Estimation for Passenger Vehicles Volvo Car Corporation SILVA, MICHAEL THOMAS 3663 §103 Final Rejection 1d overdue Pending Nov 27, 2024
18868856 AEROBIC BIOLOGICAL WASTEWATER TREATMENT IN A CONTINUOUS FLOW REACTOR Haskoningdhv Nederland B.V. NGUYEN, BOI-LIEN THI 1779 §103§112 Non-Final OA — Pending Nov 25, 2024
18866584 A HARD SURFACE CLEANING COMPOSITION CONOPCO, INC. PAUL, SHREYA §103 Final Rejection — Pending Nov 18, 2024
18942822 Microbiota of infants born by caesarean section Nutricia Early Life Nutrition (Shanghai) Co., Ltd. EDWARDS, JESSICA FAYE §102§103§112DP Non-Final OA — Pending Nov 11, 2024
18859559 CUP AND BLANK FOR FORMING CONOPCO, INC. DEMEREE, CHRISTOPHER R §102§112 Non-Final OA — Pending Oct 24, 2024
18858774 Method, pharmacy, dispensing device, medication dispensing container and computer program product for dispensing discrete medicaments VMI Holland B.V. MARU, TEMESGEN MALLEDE §112 Non-Final OA — Pending Oct 22, 2024
18858762 Bar-code printing device, method and computer program product for printing bar-codes VMI Holland B.V. HUNTSINGER, PETER K §102§103§112 Non-Final OA — Pending Oct 22, 2024
18857466 IMPROVEMENTS TO INTRODUCER SHEATHS Three Peaks Medical Pty Ltd. MILLER, SERENITY A 3771 §103§112Other Non-Final OA — Pending Oct 17, 2024
18912628 SHEET FOR USE IN PILL PACKAGES, AND POUCH FORMED FROM A SHEET VMI Holland B.V. ACKUN, JACOB K 3736 §102§103 Final Rejection 53d Pending Oct 11, 2024
18911290 METHOD FOR ENHANCING EMBRYO IMPLANTATION Nulife B.V. PARK, HAEJIN S §103§112DP Non-Final OA — Pending Oct 10, 2024
18849557 LARGE SCALE MANUFACTURING OF IPSC DERIVED HSC AND PROGENY Celyntra Therapeutics SA MIANO, JOSEPH PAUL §102§103§112 Non-Final OA — Pending Sep 23, 2024
18847267 ILLUMINATOR END PART Crea Ip B.V. TRAN, HOANG Q §102§103 Non-Final OA — Pending Sep 16, 2024
18882804 Nutritional composition for cancer N.V. Nutricia BOECKELMAN, JACOB A §103 Non-Final OA — Pending Sep 12, 2024
18882816 Cutting apparatus with auxiliary mounting system for cutting tool housing Fam ALIE, GHASSEM 3724 §103§112 Final Rejection 16d Pending Sep 12, 2024
18843752 PROCESS FOR THE PRODUCTION OF A STRUCTURED PROTEIN PRODUCT CONOPCO, INC. MORNHINWEG, JEFFREY P §102§103 Non-Final OA — Pending Sep 04, 2024
18817331 Fatty acids for boostering ketogenic diet N.V. Nutricia MUKHOPADHYAY, BHASKAR §103§112 Non-Final OA — Pending Aug 28, 2024
18815872 Fatty acids for ketosis control N.V. Nutricia WILSON, JERICA KATLYNN §101§102§103§112 Non-Final OA — Pending Aug 27, 2024
18840549 A CHIMERIC ENDOLYSIN POLYPEPTIDE Micreos Human Health B.V. LANKFORD JR, LEON B §102 Non-Final OA — Pending Aug 22, 2024
18729547 A LIQUID PHARMACEUTICAL FORMULATION OF CLONIDINE HYDROCHLORIDE Novumgen Limited PETRITSCH, AMANDA MICHELLE 1612 §102§103§112DP Non-Final OA — Pending Jul 17, 2024
18772309 Ophthalmic dye composition Vitreq B.V. WESTERBERG, NISSA M 1618 §103 Final Rejection 35d overdue Pending Jul 15, 2024
18764454 Degradation of fluor containing substances by bioconversion UNIVERSITEIT UTRECHT HOLDING B.V. NORRIS, CLAIRE A §102§112 Non-Final OA — Pending Jul 05, 2024
18757549 Delivery systems for TNE Keygene N.V. PAGE, BRENT T 1663 DP Final Rejection 15d Pending Jun 28, 2024
18723470 Microbial communities UNIVERSITEIT GENT ARIANI, KADE 1651 §103§112 Non-Final OA — Pending Jun 24, 2024
18741853 Mix of specific Bifidobacterium species and specific non-digestible oligosaccharides N.V. Nutricia YOO, HONG THI 1792 §103§112 Non-Final OA — Pending Jun 13, 2024
18731379 SYSTEM AND METHOD FOR ACTIVATING A SURGICAL INSTRUMENT, AND FOOT SWITCH ASSEMBLY FOR CONTROLLING A SURGICAL INSTRUMENT Crea Ip B.V. ROANE, AARON F 3792 §102§112 Final Rejection 6d Pending Jun 03, 2024
18661774 Surgical Instrument and Surgical System Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis OGLES, MATTHEW ERIC 3791 §103§112 Final Rejection — Pending May 13, 2024
18707187 Beta2-adrenergic receptor antagonists for use in treating diabetes or obesity Novelyeast BV NOTTINGHAM, KYLE GREGORY §103§112 Non-Final OA — Pending May 03, 2024
18706002 DISCHARGING SYSTEM FOR A HOPPER Ihc Holland Ie B.V. MAYO, TARA LEIGH 3671 §103 Non-Final OA — Pending Apr 30, 2024
18704937 Removal of micropollutants from water and installation for use therein Wageningen Universiteit ROTONDI, CONNOR JON 1778 §103§112 Non-Final OA — Pending Apr 26, 2024
18704078 New conductive additive in lithium and sodium batteries Carbonx Ip 10 B.V. MCKINNON, LASHAWNDA T §103 Non-Final OA — Pending Apr 24, 2024
18701947 CONTAINER FOR FOOD PRODUCTS CONOPCO, INC. SANGHERA, SYMREN K 3735 §102§103§112Other Non-Final OA 14d Pending Apr 17, 2024
18638605 METHOD FOR CONTROLLING A BICYCLE ELECTRONIC SYSTEM, USER INTERFACE FOR A BICYCLE ELECTRONIC SYSTEM, AND BICYCLE ELECTRONIC SYSTEM Campagnolo S.r.l. STANLEY, TYLER JAY 3611 §102§103 Final Rejection — Pending Apr 17, 2024
18700272 FILMS AND CAPSULES CONOPCO, INC. DOUYON, LORNA M 1761 §103 Final Rejection 9d Pending Apr 11, 2024
18696372 FERTILIZERS COMPRISING POTASSIUM AND POTASSIUM SOLUBILIZING MICROORGANISMS Tessenderlo Group NV LANGEL, WAYNE A §102§103§112 Non-Final OA — Pending Mar 28, 2024
18693994 Tiltable Mast Cobra Beheer B.V. AWAD, AMR A 2621 §102§112 Final Rejection — Pending Mar 21, 2024
18693999 Ballasted liftable support frame for Amusement Ride Cobra Beheer B.V. ELLIOTT, ANDREW JAMES 3711 §103 Final Rejection — Pending Mar 21, 2024
18607598 ELECTRONIC DEVICE AND METHOD FOR DETERMINING HUMAN HEIGHT USING NEURAL NETWORKS N.V. Nutricia KELLEY, CHRISTOPHER S 2482 §103 Final Rejection 28d overdue Pending Mar 18, 2024
18602064 Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases N.V. Nutricia MI, QIUWEN 1655 §103§112 Non-Final OA — Pending Mar 12, 2024
18687856 Improved methods for production of cyclic guanosine-monophosphate analogues Mireca Medicines GmbH HIBSHMAN, SARAH GRACE §102§103§112 Non-Final OA — Pending Feb 29, 2024
18685509 OXY-STEAM BIOMASS GASIFICATON SYSTEM FOR GENERATING HYDROGEN RICH SYNGAS Indian Institute Of Science AKRAM, IMRAN §102§112 Non-Final OA — Pending Feb 22, 2024
18683805 FILMS AND CAPSULES CONOPCO, INC. JACKSON, MONIQUE R 1787 §102§103§112 Non-Final OA 27d Pending Feb 15, 2024
18682132 FILMS AND CAPSULES CONOPCO, INC. ASDJODI, MOHAMMADREZA 1767 §103DP Final Rejection 59d overdue Pending Feb 08, 2024
18294183 TREATMENT USING THERMOSENSITIVE LIPOSOMES Thermosome GmbH SONG, JIANFENG 1613 §103§112DP Final Rejection — Pending Feb 01, 2024
18578751 AQUEOUS BUMETANIDE-CONTAINING LIQUID Dripel B.V. MAEWALL, SNIGDHA 1612 §103 Non-Final OA — Pending Jan 12, 2024
18571755 Allele-specific silencing therapy for DFNA21 using antisense oligonucleotides Stichting Radboud Universitair Medisch Centrum SHIN, DANA H §101§102§103§112 Non-Final OA — Pending Dec 19, 2023
18570110 Heat-transfer fluid with low electrical conductivity comprising a vinyl pyrrolidone polymer, methods for its preparation and uses thereof Arteco NV WALKER, AJA ARYANNA §103§112 Non-Final OA — Pending Dec 14, 2023
18565115 LIQUID COMPOSITIONS COMPRISING DISSOLVED THIOSULFATE AND SUSPENDED SOLIDS Tessenderlo Group NV LANGEL, WAYNE A 1731 §103§112Other Non-Final OA — Pending Nov 29, 2023
18565122 LIQUID FERTILIZERS COMPRISING DISSOLVED FERTILIZER AND SUSPENDED SOLIDS COMPRISING CALCIUM Tessenderlo Group NV LANGEL, WAYNE A 1731 §103§112DP Non-Final OA — Pending Nov 29, 2023
18564620 Lactation stage specific infant nutrition N.V. Nutricia LIU, DEBORAH YANG-HAO 1791 §103 Final Rejection — Pending Nov 28, 2023
18564885 CYTOSOLIC DELIVERY OF GENOME EDITING TOOLS Sapreme Technologies B.V. SU-TOBON, QIWEN NMN §101§102§103§112DP Non-Final OA — Pending Nov 28, 2023
18564621 Insect cell production of parvoviral vectors with modified capsid proteins UNIQURE BIOPHARMA B.V. CORNELIUS, CLAIRE ADRIENNE 1672 §103§112 Non-Final OA — Pending Nov 28, 2023
18564111 PARTICUALTE BOUILLON COMPOSITION CONOPCO, INC. BEKKER, KELLY JO 1792 §103§112 Non-Final OA — Pending Nov 27, 2023
18563934 HYDROTHERMAL TREATMENT OF BIOMASS Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno HINES, LATOSHA D 1771 §102§103§112 Final Rejection 36d overdue Pending Nov 24, 2023
18561303 SILICIC ACID IN AQUACULTURE Barlaa B.V. CALLAWAY, SPENCER THOMAS 3642 §102§103§112 Non-Final OA — Pending Nov 16, 2023
18561309 IMPROVED METHOD FOR PREPARATION OF PROTEIN-ENRICHED PRODUCTS FROM PLANT MATERIAL Napiferyn Biotech Sp. Z O.O GWARTNEY, ELIZABETH A 1759 §103§112 Non-Final OA — Pending Nov 16, 2023
18560935 Recyclable artificial turf and HDPE backing layer for recyclable artificial turf Ten Cate Thiolon B.V. EMRICH, LARISSA ROWE 1789 §103§112 Final Rejection 15d overdue Pending Nov 15, 2023
18557302 A massage coaching method, device and application thereof Nutricia Early Life Nutrition (Shanghai) Co., Ltd. NGUYEN, HIEP VAN 3686 §101§103 Non-Final OA — Pending Oct 26, 2023
18557304 Galactooligosaccharides for improving immune response N.V. Nutricia SCHACHERMEYER, SAMANTHA LYNN 1693 §103 Final Rejection 13d Pending Oct 26, 2023
18556117 IMPROVED PHOTONIC PACKAGING Sentea NV CHU, CHRIS H 2874 §103§112 Non-Final OA — Pending Oct 19, 2023
18555016 Nano-structured carbon coated silicon material and manufacturing method for use in lithium ion based secondary batteries E-Magy B.V. YUEN, JACKY 1735 §103 Non-Final OA — Pending Oct 12, 2023
18554803 UNDERARM SPRAY DELIVERY DEVICE Xero Pharmaceuticals Ip B.V. KIM, CHRISTOPHER S 3752 §103§112 Non-Final OA 31d overdue Pending Oct 11, 2023
18375392 METHODS FOR PRODUCING SINGLE INSECT CELL CLONES UNIQURE BIOPHARMA B.V. POPA, ILEANA 1633 §103§112 Final Rejection — Pending Sep 29, 2023
18548909 Stable storage of enzymes Nextkidney Sg Pte. Ltd. ROBINSON, HOPE A 1652 §103 Final Rejection 39d Pending Sep 04, 2023
18547703 PRODUCT FOR MACHINE DISHWASHING IN THE FORM OF A CAPSULE WITH MULTIPLE COMPARTMENTS CONOPCO, INC. DELCOTTO, GREGORY R 1761 §103§112 Final Rejection 2d overdue Pending Aug 24, 2023
18546287 TEXTURED SURFACES OF BIOCOMPATIBLE POLYMERIC MATERIALS Instructure Labs B.V. SPENCER, MAXIMILIAN TOBIAS 3774 §102§103Other Non-Final OA 9d Pending Aug 14, 2023
18264587 Curing disease by transcription regulatory gene editing Koninklijke Nederlandse Akademie Van Wetenschappen LIPPOLIS, ALEXANDRA ROSE 1637 §103§112 Final Rejection — Pending Aug 08, 2023
18264085 TWO-STAGE COOLING PROCESS FOR LARVAE PUREE Protix B.V. LIU, DEBORAH YANG-HAO 1791 §102§103 Final Rejection 56d Pending Aug 03, 2023
18261292 A METHOD TO PREPARE POCKETS OF ENCAPSULATED MATERIAL COMPRISING A CORE SURROUNDED BY AN ENCAPSULATION UNIVERSITEIT GENT ANGEBRANNDT, MARTIN J 1737 §103§112 Non-Final OA — Pending Jul 13, 2023
18260948 TUMOR SENSOR SYSTEM FOR TUMOR LOCALIZATION, THERAPY RESPONSE, AND IMAGE GUIDED SURGERY Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis MALDONADO, STEVEN 3797 §103§112 Non-Final OA — Pending Jul 11, 2023
18260942 SEALING STRIP FOR SEALING JOINTS BETWEEN THE SURFACES OF TWO ADJACENT COMPONENTS UNIVERSITEIT GENT KENNY, DANIEL J 3633 §103 Final Rejection — Pending Jul 11, 2023
18258814 Expandable plug Stichting Radboud Universitair Medisch Centrum DAVID, SHAUN L 3771 §102§103 Final Rejection 13d Pending Jun 22, 2023
18256057 FIBRE MIXTURE FOR YOUNG CHILDREN N.V. Nutricia CREWS, JARET JAMES 1691 §103 Non-Final OA 16d Pending Jun 06, 2023
18254178 New production method of carbon (nano)-structures from pyrolysis oil Carbonx B.V. PHAN, ANNETTE HOANG-ANH 1736 §103§112 Non-Final OA — Pending May 24, 2023
18254198 COMPOSITION FOR MAKING BOUILLONS CONOPCO, INC. LEBLANC, KATHERINE DEGUIRE 1791 §103§112 Final Rejection — Pending May 24, 2023
18254179 Ribosomal profiling in single cells Koninklijke Nederlandse Akademie Van Wetenschappen BUCHANAN, BAILEY CHEYENNE 1682 §102§103 Final Rejection 9d overdue Pending May 24, 2023
18311910 Method for providing dynamically customized messages in a healthcare facility Tools4Patient BALAJ, ANTHONY MICHAEL 3682 §101 Final Rejection 49d overdue Pending May 04, 2023
18246681 A NOVEL PHAGE FOR LISTERIA, INCLUDING LISTERIA MONOCYTOGENES Micreos Food Safety B.V. CURRENS, GRANT CARSON 1651 §112 Final Rejection 17d overdue Pending Mar 27, 2023
18245066 INTERNALIZING BINDING MOLECULES Linxis B.V. HUYNH, PHUONG N 1641 §112Other Final Rejection — Pending Mar 13, 2023
18043595 OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS Intravacc B.V. OGUNBIYI, OLUWATOSIN A 1645 §101§102§112 Non-Final OA 53d overdue Pending Mar 01, 2023
18042779 OPHTHALMIC DYE Vitreq B.V. VU, JAKE MINH 1618 §103§112 Final Rejection 53d overdue Pending Feb 24, 2023
18154088 Vanadyl and vanadate for use in reducing stress-induced metabolic derangement Cfm Pharma Holding B.V. BECKHARDT, LYNDSEY MARIE 1613 §103DP Final Rejection 43d overdue Pending Jan 13, 2023
18012754 COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE Sapreme Technologies B.V. SKOKO III, JOHN JOSEPH 1643 §103Other Non-Final OA — Pending Dec 23, 2022
18012729 CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION Sapreme Technologies B.V. CHO, DAVID H 1693 §103DP Final Rejection — Pending Dec 23, 2022
18012760 COMBINATION OF AN ANTIBODY-DRUG CONJUGATE AND AN ANTIBODY-SAPONIN CONJUGATE Sapreme Technologies B.V. HUYNH, PHUONG N 1641 §103§112Other Final Rejection — Pending Dec 23, 2022
18012741 COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE Sapreme Technologies B.V. SKOKO III, JOHN JOSEPH 1643 §103Other Final Rejection 26d Pending Dec 23, 2022
18012791 HYDRAZONE-BASED SAPONIN DERIVATIVES Sapreme Technologies B.V. HIBSHMAN, SARAH GRACE 1693 §103§112DP Non-Final OA — Pending Dec 23, 2022
18001718 Novel Food The Protein Brewery B.V. DUBOIS, PHILIP A 1791 §103§112 Non-Final OA 36d Pending Dec 14, 2022
18001290 METHOD FOR SEPARATION OF POTATO PROTEINS AND INSOLUBLE FIBERS FROM PHENOLIC AND/OR GLYCOALKALOID COMPOUNDS Duynie Holding B.V. SHELLHAMMER, JAMES PAUL 1793 §103Other Final Rejection 44d overdue Pending Dec 09, 2022
18001272 METHOD FOR SEPARATION OF POTATO PROTEINS WITH REDUCED ENZYMATIC ACTIVITY FROM POTATO FRUIT JUICE Duynie Holding B.V. SHELLHAMMER, JAMES PAUL 1793 §103§112Other Non-Final OA — Pending Dec 09, 2022
17926668 Screening method for effective target - E3 ligase combinations UMC Utrecht Holding B.V. BORGEEST, CHRISTINA M 1675 §103 Final Rejection 26d overdue Pending Nov 21, 2022
17922987 VAGINAL DEVICE FOR PROLAPSE TREATMENT Stichting Radboud Universitair Medisch Centrum HAN, ROBIN 3786 §103 Final Rejection 111d overdue Pending Nov 03, 2022
17921365 PROCESS FOR THE PREPARATION OF A FLAVOURING CONOPCO, INC. MERRIAM, ANDREW E 1791 §103§112Other Non-Final OA 4d overdue Pending Oct 26, 2022
17921372 Yeast strains for reducing contamination by lactic acid bacteria UNIVERSITE LIBRE DE BRUXELLES RAGHU, GANAPATHIRAM 1652 §102§103§112 Non-Final OA 23d Pending Oct 26, 2022
17920418 Meltable Fuse Tchüpp GmbH SADLON, JOSEPH 3635 §103 Non-Final OA 56d Pending Oct 21, 2022
17920413 METHOD FOR LAYER-BY-LAYER DEPOSITION OF CONCRETE UNIVERSITEIT GENT INSLER, ELIZABETH 1774 §102 Final Rejection — Pending Oct 21, 2022
17918932 USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS Pharming Intellectual Property B.V. HELLMAN, KRISTINA M 1654 §112DP Final Rejection 25d overdue Pending Oct 14, 2022
17917265 REMOVING WATER-SOLUBLE HEAVY METAL-SULFUR COMPLEX FROM PROCESS SOLUTION Tessenderlo Kerley, Inc. KEYWORTH, PETER 1777 §103§112 Non-Final OA 43d overdue Pending Oct 06, 2022
17961097 GENE CONSTRUCTS FOR SILENCING ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND USES THEREOF Uniqure IP B.V. ANGELL, JON E 1637 §103 Final Rejection 114d overdue Pending Oct 06, 2022
17948862 NOVEL CELL LINE UNIQURE BIOPHARMA B.V. LEVIN, JOEL D 1633 Other Non-Final OA 42d Pending Sep 20, 2022
17908545 Membrane Ubiquitin ligases to target protein degradation UMC Utrecht Holding B.V. LUNDE, GRACE HENRY 1641 §103§112DP Non-Final OA 19d Pending Sep 01, 2022
17802981 Pasteurisation of microbial biomass suitable for food applications The Protein Brewery B.V. GWARTNEY, ELIZABETH A 1759 §103 Final Rejection — Pending Aug 29, 2022
17797986 COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES Danmarks Tekniske Universitet LIPPOLIS, ALEXANDRA ROSE 1637 §102§103 Non-Final OA 5d overdue Pending Aug 05, 2022
17797448 USE OF A SOLUBLE GUANYLATE CYCLASE (sGC) STIMULATOR OR OF A COMBINATION OF A sGC STIMULATOR AND AN sGC ACTIVATOR FOR CONDITIONS WHEREIN THE HEME GROUP OF sGC IS OXIDIZED OR WHEREIN sGC IS DEFICIENT IN HEME Academisch Ziekenhuis Maastricht SIMMONS, CHRIS E 1622 §103§112 Final Rejection 22d overdue Pending Aug 04, 2022
17797450 THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA Academisch Ziekenhuis Maastricht PEEBLES, KATHERINE 1617 §102§103§112 Non-Final OA 189d overdue Pending Aug 04, 2022
17852435 Injector device Crea Ip B.V. FREHE, WILLIAM R 3783 §102§103 Non-Final OA — Pending Jun 29, 2022
17786579 THRIPS CONTROL Protix B.V. MARTIN, PAUL C 1653 §103 Final Rejection 212d overdue Pending Jun 17, 2022
17785412 CONFECTIONERY PRODUCT WITH REDUCED AMOUNT OF SUGAR AND MANUFACTURING PROCESS THEREOF Perfetti Van Melle Benelux B.V. LACHICA, ERICSON M 1792 §103Other Non-Final OA 60d overdue Pending Jun 15, 2022
17783023 PURIFIED NON-DAIRY VEGETABLE PROTEIN N.V. Nutricia GERLA, STEPHANIE RAE 1791 §103 Non-Final OA 63d Pending Jun 07, 2022
17780002 CONSTRUCTS, COMPOSITIONS AND METHODS THEREOF HAVING IMPROVED GENOME EDITING EFFICIENCY AND SPECIFICITY Danmarks Tekniske Universitet GROOMS, TIFFANY NICOLE 1637 §103§112 Non-Final OA 72d Pending May 25, 2022
17777639 Macromolecular compositions for binding small molecules UMC Utrecht Holding B.V. CHIU, TAK LIANG 1777 §103 Non-Final OA — Pending May 18, 2022
17776604 Porous membranes comprising sorbent particles for improved urea capture UNIVERSITEIT TWENTE MCDERMOTT, JEANNIE 1777 §103 Non-Final OA 78d Pending May 13, 2022
17775890 INFANT FORMULA WITH SPECIAL LIPID ARCHITECTURE FOR IMPROVING POSTNATAL GROWTH OF INFANTS BORN TO OVERWEIGHT AND OBESE MOTHERS N.V. Nutricia MERRIAM, ANDREW E 1791 §103§112 Final Rejection — Pending May 11, 2022
17767096 Use of an anti-CCR7 antibody in combination therapies with a BTK inhibitor and/or BCL2- inhibitor for treating hematological malignancies Immunological And Medicinal Products, Sl ALLEN, MARIANNE P 1647 §103§112 Final Rejection 25d overdue Pending Apr 07, 2022
17710929 COMPOSITIONS COMPRISING PLANT-DERIVED EXOSOME-LIKE NANOVESICLES OR EXOSOMES AND METHODS OF USE THEREOF Nutraceutical Wellness, Inc. ANTHOPOLOS, PETER 1611 §101 Non-Final OA 29d overdue Pending Mar 31, 2022
17760508 Method for the conversion of insects into nutrient streams and products resulting therefrom Protix B.V. LACHICA, ERICSON M 1792 §103§112 Non-Final OA 60d overdue Pending Mar 15, 2022
17685881 METHODS OF ANTIBODY PANNING AGAINST TARGET PROTEINS Alegre Usa LLC PARISI, JESSICA DANIELLE 1684 §102§103 Final Rejection 26d Pending Mar 03, 2022
17676877 Modified hexa-acylated neisserial LPS Intravacc B.V. DICKENS, AMELIA NICOLE 1645 Other Non-Final OA — Pending Feb 22, 2022
17629598 BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY Sapreme Technologies B.V. LEE, HOI YAN NMN 1693 §103Other Final Rejection 34d Pending Jan 24, 2022
17621242 Polysulfide Compositions and Processes for Making Same Tessenderlo Kerley, Inc. SHERMAN, ERIC SCOTT 1736 §102 Non-Final OA — Pending Dec 21, 2021
17618895 Silicate based heat transfer fluid, methods of its preparations and uses thereof Arteco N.V. GODENSCHWAGER, PETER F 1767 §103 Final Rejection 2d overdue Pending Dec 14, 2021
17546089 Method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonist Stichting Radboud Universitair Medisch Centrum FERNANDEZ, SUSAN EMILY 1651 §103 Non-Final OA 86d overdue Pending Dec 09, 2021
17615589 Biomass composition comprising insect particles, method for producing the same, and use of said biomass composition Protix B.V. SILVA RAINBOW, HEATHER ELISE 1731 §103 Final Rejection 16d Pending Dec 01, 2021
17611197 Composition comprising vitamin A and non digestible oligosaccharides N.V. Nutricia YOO, HONG THI 1792 §103§112 Final Rejection — Pending Nov 15, 2021
17609013 COMPOSITIONS COMPRISING FIBRILLATED CELLULOSE AND NON-IONIC CELLULOSE ETHERS Coöperatie Koninklijke Cosun U.A. CORALLO, CATRIONA MARY 1732 §103 Final Rejection 131d overdue Pending Nov 05, 2021
17608543 Structuring agents Coöperatie Koninklijke Cosun U.A. LIOTT, CAROLINE DUSHECK 1732 §103Other Non-Final OA 21d Pending Nov 03, 2021
17508481 USE OF VANADIUM COMPOUNDS FOR MAINTAINING NORMAGLYCEMIA IN A MAMMAL Cfm Pharma Holding BV BOECKELMAN, JACOB A 1655 §103§112 Non-Final OA 70d Pending Oct 22, 2021
17605097 Methods and Compositions for Isothermal DNA Amplification Synvolux IP B.V. YU, TIAN NMN 1681 §103 Final Rejection 49d overdue Pending Oct 20, 2021
17489967 GLASSES PROVIDED WITH A PHOTON SOURCE, SYSTEM COMPRISING SUCH GLASSES AND USE OF SUCH GLASSES IN PHOTOTHERAPY Chrono Eyewear B.V. TEHRANI, DANIEL 3700 §103 Final Rejection — Pending Sep 30, 2021
17441704 Chitosan nitrate for use as a nitric oxide donor (NO donor) No-Ceuticals B.V. LEE, HOI YAN NMN 1693 §103 Non-Final OA 8d Pending Sep 22, 2021
17443656 PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PANCREATIC CANCER Amphera B.V. TRAN, KHOA NHAT 1632 §103Other Non-Final OA — Pending Jul 27, 2021
17415759 DRUG CONJUGATE Sapreme Technologies B.V. ZARA, JANE J 1637 §103§112DP Final Rejection 30d overdue Pending Jun 18, 2021
17312104 Saponin Conjugates Sapreme Technologies B.V. BAKSHI, PANCHAM 1623 §102§112 Non-Final OA — Pending Jun 09, 2021
17312193 SAPONIN CONJUGATED TO EPITOPE-BINDING PROTEINS Sapreme Technologies B.V. HUYNH, PHUONG N 1641 §103§112Other Final Rejection 22d Pending Jun 09, 2021
17299800 DRESSING CONOPCO, INC. KIM, BRYAN 1792 §103 Non-Final OA 21d Pending Jun 04, 2021
17298957 Antisense Oligonucleotides Rescue Aberrant Splicing of ABCA4 Stichting Katholieke Universiteit TRAN, CHRISTINA L 1637 §103§112 Final Rejection — Pending Jun 02, 2021
17290264 Native whey protein for improving intestinal maturation N.V. Nutricia D' AMBROSIO, THEA 1654 §112 Non-Final OA 42d overdue Pending Apr 30, 2021
17285098 Novel chemiluminescent substrates for Factor Xa Enzyre B.V. KOMATSU, LI N 1658 §103DP Non-Final OA — Pending Apr 14, 2021
17283265 Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection N.V. Nutricia CRUM, MARY ABOU NADER 1657 §103DP Final Rejection 62d Pending Apr 07, 2021
17283287 NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE N.V. Nutricia CRUM, MARY ABOU NADER 1657 DP Non-Final OA 4d overdue Pending Apr 07, 2021
16970962 AQUEOUS COMPOSITION CONTAINING SALT, ACETIC ACID, AND SUGARS CONOPCO, INC. KOHLER, STEPHANIE A 1791 §103 Non-Final OA — Pending Aug 19, 2020
16869707 ASSOCIATIVE POLYMER STRUCTURES AND METHODS OF USE THEREOF Energy Solutions (Us) LLC REDDY, KARUNA P 1764 §103 Non-Final OA 72d overdue Pending May 08, 2020

Managing Ipsilon Usa - Nlo's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month